BRUNELLO, Nicoletta
 Distribuzione geografica
Continente #
NA - Nord America 10.114
EU - Europa 5.566
AS - Asia 1.082
OC - Oceania 24
SA - Sud America 23
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 16.827
Nazione #
US - Stati Uniti d'America 10.036
GB - Regno Unito 1.559
DE - Germania 1.455
IT - Italia 882
SE - Svezia 628
CN - Cina 382
HK - Hong Kong 344
RU - Federazione Russa 212
UA - Ucraina 210
BG - Bulgaria 167
FI - Finlandia 147
TR - Turchia 140
FR - Francia 87
IE - Irlanda 81
IN - India 64
SG - Singapore 63
CA - Canada 61
BE - Belgio 24
AU - Australia 22
CH - Svizzera 19
ES - Italia 16
JP - Giappone 16
RO - Romania 16
BR - Brasile 12
MX - Messico 12
PL - Polonia 12
VN - Vietnam 12
LT - Lituania 10
NL - Olanda 10
IR - Iran 8
DK - Danimarca 6
EG - Egitto 6
KR - Corea 6
TW - Taiwan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
CL - Cile 5
ID - Indonesia 5
IL - Israele 5
PK - Pakistan 5
TH - Thailandia 5
AR - Argentina 4
GR - Grecia 4
MY - Malesia 4
SI - Slovenia 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CZ - Repubblica Ceca 3
EU - Europa 3
HU - Ungheria 3
KZ - Kazakistan 3
MD - Moldavia 3
AN - Antille olandesi 2
BZ - Belize 2
IQ - Iraq 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SA - Arabia Saudita 2
BD - Bangladesh 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
EE - Estonia 1
HT - Haiti 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MA - Marocco 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
SD - Sudan 1
Totale 16.827
Città #
Fairfield 1.579
Southend 1.265
Chandler 1.038
Woodbridge 831
Ashburn 800
Houston 646
Wilmington 539
Cambridge 484
Seattle 450
Jacksonville 430
Nyköping 407
Hong Kong 330
Dearborn 326
Ann Arbor 322
Modena 270
San Diego 216
Princeton 187
Sofia 167
Beijing 146
Helsinki 80
Dublin 79
Eugene 77
New York 73
Izmir 67
Los Angeles 67
London 62
Des Moines 57
Falls Church 48
Fremont 45
Redwood City 41
Milan 39
Norwalk 37
Shanghai 30
Bremen 27
Rome 27
Bologna 24
San Mateo 23
Brussels 21
Kilburn 20
Parma 20
Hounslow 19
Catania 18
Nanjing 18
Toronto 18
San Francisco 17
Boardman 15
Ottawa 14
Phoenix 14
Reggio Emilia 14
Frankfurt am Main 13
Hefei 13
Chiswick 12
San Giuliano Milanese 12
Verona 11
Chicago 10
Vancouver 10
Dong Ket 9
Kunming 9
Liebefeld 9
Sydney 9
Auburn Hills 8
Guangzhou 8
Prescot 8
Bari 7
Central District 7
Indiana 7
Istanbul 7
Leawood 7
Paris 7
Augusta 6
Florence 6
Paderno Dugnano 6
Tappahannock 6
Zhengzhou 6
Ardabil 5
Chengdu 5
Dongguan 5
Iasi 5
Jinan 5
Konya 5
Leicester 5
Madrid 5
Mexico City 5
Mumbai 5
Priverno 5
Tokyo 5
Vicenza 5
Amsterdam 4
Brembate di Sopra 4
Brescia 4
Buffalo 4
Chennai 4
Clearwater 4
Como 4
Fuzhou 4
Hebei 4
Islington 4
Kemerovo 4
Maser 4
Mountain View 4
Totale 11.874
Nome #
Disease-induced neuroinflammation and depression 288
N-acetyl-cysteine prevents toxic oxidative effects induced by IFN-α in human neurons. 288
Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment 264
Successful treatment of HIV-1 infection increases the expression of a novel, short transcript for IL-18 receptor α chain 259
LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response 242
Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in a rat model of depression 230
Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain 228
Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2 227
P.2.a.012 Co-administration of fluoxetine with acetylsalicylic acid, but not flurbiprofen or celecoxib, for one week shows an antidepressant-like effect 225
Hypothalamic expression of inflammatory mediators in an animal model of binge eating 223
Interferon alpha exposure increases the expression of the enzymes belonging to the kynurenine pathway in an in vitro model of human neurons: SH-SY5Y cells 221
Stress induces altered CRE/CREB pathway activity and BDNF expression in the hippocampus of glucocorticoid receptor-impaired mice 219
Molecular changes associated with escitalopram response in a stress-based model of depression 218
Interleukin 18 activates MAPKs and STAT3 but not NF-κB in hippocampal HT-22 cells 217
Erratum to: Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2 (J Neuroimmune Pharmacol, 2015, DOI 10.1007/s11481-015-9641-x) 217
Transcriptional profiles underlying vulnerability and resilience in rats exposed to an acute unavoidable stress 215
Chronic antidepressant treatments resulted in altered expression of genes involved in inflammation in the rat hypothalamus 215
Behavioural and transcriptional effects of escitalopram in the chronic escape deficit model of depression 211
Fluoxetine treatment affects the inflammatory response and microglial function according to the quality of the living environment 209
Chronic treatment with the selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats 208
Neonatal persistent inflammation alters pain response and NMDA receptor expression in adult mice 205
Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression 202
Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats 202
Lymnaea stagnalis as model for translational neuroscience research: from pond to bench 202
Central effects of a local inflammation in three commonly used mouse strains with a different anxious phenotype 200
Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats. 197
Early neonatal inflammation affects adult pain reactivity and anxiety related traits in mice: genetic background counts 196
Altered regulation of CREB by chronic antidepressant administration in the brain of transgenic mice with impaired glucocorticoid receptor function. 189
Mitochondrial energy metabolism of rat hippocampus after treatment with the antidepressants desipramine and fluoxetine 188
Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study 183
Microarray analysis of the chronic escape deficit model of depression: Effects of escitalopram treatment in hippocampus 182
P.1.04 Expression of histone variants H3.3 and H2a.z in the rat brain: Physiopathological and pharmacological implications 182
Effects of acute stress on brain-derived neurotrophic factor in the hippocampus of transgenic mouse model of depression 178
Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders 174
HTR1B as a risk profile maker in psychiatric disorders:a review through motivation and memory 174
Behavioural and molecular effects of the combined treatment fluoxetine plus acetylsalicylic acid in a rat model of depression 174
Effect of reboxetine treatment on brain cAMP- and calcium/calmodulin-dependent protein kinases 172
Cognitive deficits and changes in gene expression of NMDA receptors after prenatal methylmercury exposure 171
Modulation of neuroplasticity-related targets following stress-induced acute escape deficit 171
Early postnatal chronic inflammation produces long-term changes in pain behavior and N-methyl-D-aspartate receptor subtype gene expression in the central nervous system of adult mice 170
Cloning of mouse Ca2+/calmodulin-dependent protein kinase kinase beta (CaMKKbeta) and characterization of CaMKKbeta and CaMKKalpha distribution in the adult mouse brain. 167
Impaired stress-induced regulation of brain derived neurotrophic factor expression in hippocampus of glucocorticoid receptor impaired mice: Model of depression 165
Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression 163
Interferon-alpha exposure increases the expression of enzymes of the kynurenine pathway and induces apoptosis in a model of human neurons 162
Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKK alpha and CaMKK beta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor 162
Fluoxetine prevents Aβ1-42-induced toxicity via a paracrine signaling mediated by transforming-growth-factor-β1 162
Regulation of CREB function in rat frontal cortex after combined treatment with Fluoxetine and Olanzapine 161
Neither all anti-inflammatory drugs nor all doses are effective in accelerating the antidepressant-like effect of fluoxetine in an animal model of depression 159
Mood stabilizers: protecting the mood ... protecting the brain 157
Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain 156
Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria 155
Gene expression profile of the hippocampus of a behavioural model of depression 153
New combination therapies from animal to human 152
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 147
Molecular effects of subchronic andchronic treatment with escitalopram inthe rat central nervous system 142
Restraint stress increases the expression of brain derived neurotrophic factor in the hippocampus of a mouse model of depression 142
Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas 142
Combined effect of antidepressant and anti-inflammatory drugs in an animal model of depressio 141
Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic seroquel (quetiapine fumarate). . 137
Cyclic GMP inhibition of metabotropic glutamate receptor-induced phosphoinositide hydrolysis in mesencephalic neurons 135
Combined fluoxetine and metformin treatment potentiates antidepressant efficacy increasing IGF2 expression in the dorsal hippocampus 132
The role of noradrenaline and selective noradrenaline reuptake inhibition in depression 131
Metabolic characterization of SH-SY5Y cells and effects of interferon-alpha exposure 130
Vortioxetine Prevents Lipopolysaccharide-Induced Memory Impairment Without Inhibiting the Initial Inflammatory Cascade 129
Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment 128
Interplay between inflammation and neural plasticity: Both immune activation and suppression impair LTP and BDNF expression 128
cAMP-dependent phosphorylation system after short and long-term administration of moclobemide 126
Metabolic changes induced by interferon-α exposure in an in vitro model of human neurons 126
Practical issues in clinical research of schizophrenia 125
Effect of idebenone on in vivo serotonin release and serotonergic receptors in young and aged rats 122
Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment 121
Carnosine Protects Macrophages against the Toxicity of Aβ1-42 Oligomers by Decreasing Oxidative Stress 116
Chiralità e farmaci antidepressivi 112
Escitalopram: meccanismo d’azione e profili clinico 109
Deciphering the central immunomodulatory effects of a vortioxetine pretreatment on the LPS-induced inflammatory cascade 107
Serum metabolic signature of binge-like palatable food consumption in female rats by nuclear magnetic resonance spectroscopy 104
New insights into the biology of schizophrenia through the mechanism of action of clozapine. 100
Second messenger-regulated protein kinases in the brain: Their functional role and the action of antidepressant drugs 95
Hippocampus-related effects of fluoxetine treatment under stressful vs enriched conditions 93
P.304 Executive functioning and genetic variation in pediatric patients with cancer 86
Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit NMDA receptor activity and prevent neurotoxicity in mesencephalic neuron in vitro 81
Environmental enrichment influences mouse hippocampal neuroinflammatory response 80
Farmacologia e neurobiologia nei disturbi d'ansia e nella depressione 71
Dysbindin, D3 receptors, and their genetic interaction differently regulate neuroplasticity genes in the mouse brain 64
ADOLESCENCE AS A CRITICAL TIME-WINDOW FOR NEUROINFLAMMATION IN THE MOUSE: WHY SEX MATTERS 59
Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: Behavioural and biochemical studies 58
BIOCHEMICAL AND MOLECULAR CHANGES IN RAT CEREBRAL CORTEX AFTER CHRONIC ANTIDEPRESSANT TREATMENT: ‘IN VITRO AND’‘IN VIVO’ STUDIES 56
Behavioural and neurochemical changes produced by lefetamine in two inbred strains of mice 54
Age‐Related Changes in Rat Serotonergic and Adrenergic Systems and in Receptor Responsiveness to Subchronic Desipramine Treatment 52
Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: Dissociation from effects on prolactin secretion 52
Behavioural changes after acute and chronic administration of typical and atypical antidepressants in rats: Interactions with reserpine 51
Behavioural and biochemical effects in C57BL/6J mice after a prolonged treatment with the δ‐opiate antagonist ICI 154129 51
Posttraumatic stress disorder: Diagnosis and epidemiology, comorbidity and social consequences, biology and treatment 51
Effects of an extract of Ginkgo Biloba on noradrenergic systems of rat cerebral cortex 50
The activity of some neurotransmitter-synthetizing enzymes in experimental cobalt epilepsy 49
cAMP-dependent binding proteins and endogenous phosphorylation after antidepressant treatment 49
Role of dopamine D3 receptors, dysbindin, and their functional interaction on the expression of key genes for neuroplasticity in the mouse brain 47
cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity 47
Identification and characterization of the kynurenine pathway in the pond snail Lymnaea stagnalis 46
Age-related changes in 5HT uptake and [3H]imipramine binding sites in rat cerebral cortex 45
Totale 14.829
Categoria #
all - tutte 80.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.945


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019775 0 0 0 0 0 0 0 0 0 0 385 390
2019/20202.978 233 166 88 138 293 457 484 323 272 96 268 160
2020/20212.841 411 88 241 263 279 232 205 288 174 311 218 131
2021/20223.346 478 258 153 241 75 233 113 137 307 351 686 314
2022/20232.866 303 255 250 293 289 441 43 307 424 28 116 117
2023/20241.748 130 127 130 222 379 157 101 278 38 101 85 0
Totale 17.145